Bevacizumab allows preservation of liver function and its regenerative capacity after major hepatectomy

JAVIER CABALLERO VILLARRASO2026-01-292026-01-29201910.2174/18715206196661904171624092-s2.0-85075609051https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/31086Cancer ResearchMolecular MedicinePharmacologyBevacizumab allows preservation of liver function and its regenerative capacity after major hepatectomyresearch article